InsiderTrades

Form 4 for CVS CVS Health

Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001127602-25-011403 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-04-03 2025-04-01 CVS COWHEY THOMAS F. EVP, CFO F - Tax $67.98 -3,203 50.2K -6% -$217.7K
D 2025-04-03 2025-04-01 CVS COWHEY THOMAS F. EVP, CFO A - Grant $67.98 +16.2K 41.1K +65% +$1.10M
D 2025-04-03 2025-04-01 CVS COWHEY THOMAS F. EVP, CFO A - Grant $67.98 +68.6K 68.6K New +$4.66M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-04-01 F D 3,203 $67.98 50,188 D — —
2 Common Common Stock (Restricted) 2025-04-01 A A 16,181 $67.98 41,109 D — —
3 Derivative Stock Option 2025-04-01 A A 68,621 $67.98 68,621 D $67.98 · 2026-04-01 to 2035-04-02 68,621 Common Stock (F3) Option becomes exercisable in four equal annual installments, commencing on 4/1/2026.